Cowen Prime Advisors’s Exact Sciences EXAS Stock Holding History

Cowen Prime Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-900	Closed	-$83K	–	201
2019 Q4	$83K	Buy	+900	New	+$79.1K	0.04%	103

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen Prime Advisors's EXAS Position: Q1 2020 in Review

Cowen Prime Advisors sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 900 shares — an estimated $83K sold.

Cowen Prime Advisors first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $83K in Q4 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

Cowen Prime Advisors reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
Cowen Prime Advisors sold 900 Exact Sciences shares in Q1 2020, an estimated $83K.
Cowen Prime Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
Cowen Prime Advisors's Exact Sciences position peaked at $83K in Q4 2019.
476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Cowen Prime Advisors's 13F filing for Q1 2020, filed 28 Apr 2020.